התחייבויות לטווח ארוך להון עצמי: autonomix.com (AMIX)

This chart illustrates the current share price of Autonomix Medical, Inc. (AMIX) on the GURU.Markets platform, where indicators stand at 0.00, supported by the top management's medtech expertise and strict licensing control. The company is developing advanced oncology catheters currently undergoing clinical trials. However, geopolitical instability is hindering microchip imports and restricting equipment exports to sanctioned regions.

Autonomix Medical, Inc. (AMIX) leverages strong pricing power in the minimally invasive chronic pain treatment segment to effectively manage its investment cycle. This indicator is calculated as the ratio of long-term liabilities to total equity. The metric determines the extent to which business development depends on external long-term borrowings. A decrease in this value indicates strengthening financial autonomy and a reduction in interest expenses. The trend of the long-term financial leverage ratio reflects the balance between expansion and balance sheet stability.